
Biotech News
Eikon Therapeutics Secures $350.7M Series D to Advance Drug Development
Eikon Therapeutics, a pivotal-stage biotechnology company, has announced the initial closing of its $350.7 million Series D financing to advance its drug discovery and development efforts. Since its founding in 2019, the company has privately raised more than $1.1 billion to support its mission